Onji Masahiro, Sigl Verena, Lendl Thomas, Novatchkova Maria, Ullate-Agote Asier, Andersson-Rolf Amanda, Kozieradzki Ivona, Koglgruber Rubina, Pai Tsung-Pin, Lichtscheidl Dominic, Nayak Komal, Zilbauer Matthias, Carranza García Natalia A, Sievers Laura Katharina, Falk-Paulsen Maren, Cronin Shane J F, Hagelkruys Astrid, Sawa Shinichiro, Osborne Lisa C, Rosenstiel Philip, Pasparakis Manolis, Ruland Jürgen, Takayanagi Hiroshi, Clevers Hans, Koo Bon-Kyoung, Penninger Josef M
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Nature. 2025 Jan;637(8044):156-166. doi: 10.1038/s41586-024-08284-1. Epub 2024 Dec 4.
During reproduction, multiple species such as insects and all mammals undergo extensive physiological and morphological adaptions to ensure health and survival of the mother and optimal development of the offspring. Here we report that the intestinal epithelium undergoes expansion during pregnancy and lactation in mammals. This enlargement of the intestinal surface area results in a novel geometry of expanded villi. Receptor activator of nuclear factor-κΒ (RANK, encoded by TNFRSF11A) and its ligand RANKL were identified as a molecular pathway involved in this villous expansion of the small intestine in vivo in mice and in intestinal mouse and human organoids. Mechanistically, RANK-RANKL protects gut epithelial cells from cell death and controls the intestinal stem cell niche through BMP receptor signalling, resulting in the elongation of villi and a prominent increase in the intestinal surface. As a transgenerational consequence, babies born to female mice that lack Rank in the intestinal epithelium show reduced weight and develop glucose intolerance after metabolic stress. Whereas gut epithelial remodelling in pregnancy/lactation is reversible, constitutive expression of an active form of RANK is sufficient to drive intestinal expansion followed by loss of villi and stem cells, and prevents the formation of Apc-driven small intestinal stem cell tumours. These data identify RANK-RANKL as a pathway that drives intestinal epithelial expansion in pregnancy/lactation, one of the most elusive and fundamental tissue remodelling events in mammalian life history and evolution.
在繁殖过程中,昆虫和所有哺乳动物等多种物种会经历广泛的生理和形态适应,以确保母体的健康和生存以及后代的最佳发育。在此,我们报告哺乳动物在怀孕和哺乳期间肠道上皮会发生扩张。肠道表面积的这种增大导致绒毛扩张呈现出新的几何形态。核因子κB受体激活剂(RANK,由TNFRSF11A编码)及其配体RANKL被确定为参与小鼠体内小肠绒毛扩张以及小鼠和人类肠道类器官绒毛扩张的分子途径。从机制上讲,RANK - RANKL保护肠道上皮细胞免于细胞死亡,并通过骨形态发生蛋白(BMP)受体信号传导控制肠道干细胞生态位,从而导致绒毛伸长和肠道表面积显著增加。作为一种跨代后果,肠道上皮缺乏Rank的雌性小鼠所生的幼崽体重减轻,在代谢应激后出现葡萄糖不耐受。虽然怀孕/哺乳期间的肠道上皮重塑是可逆的,但RANK活性形式的组成性表达足以驱动肠道扩张,随后导致绒毛和干细胞丧失,并可预防Apc驱动的小肠干细胞肿瘤的形成。这些数据确定RANK - RANKL是在怀孕/哺乳期间驱动肠道上皮扩张的一条途径,这是哺乳动物生命史和进化中最难以捉摸且最基本的组织重塑事件之一。